Sugi Predict

Sugi Predict / Compounds / SCHEMBL19737720

SCHEMBL19737720

SCHEMBL19737720

CC#CCN(C(=O)c1sc2nc(-c3cccnc3)ccc2c1N)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIMK1 P53667 2/20 0.58
▸ MAPT P10636 13/20 0.57
▸ NPC1 O15118 8/20 0.57
▸ MEN1 O00255 7/20 0.57
▸ KMT2A Q03164 7/20 0.57
▸ RAB9A P51151 6/20 0.57
▸ KDM4E B2RXH2 4/20 0.57
▸ POLB P06746 4/20 0.57
▸ MCL1 Q07820 3/20 0.57
▸ NFKB1 P19838 2/20 0.57
▸ NFKB2 Q00653 2/20 0.57
▸ RELA Q04206 2/20 0.57
▸ PKM P14618 1/20 0.57
▸ ALDH1A1 P00352 5/20 0.56
▸ SMN1; SMN2 Q16637 4/20 0.56
▸ TLR9 Q9NR96 4/20 0.51
▸ RECQL P46063 2/20 0.51
▸ HPGD P15428 2/20 0.48
▸ USP2 O75604 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19737556 0.89 LIMK1 (0.60) LIMK1MAPTNPC1MEN1KMT2A
SCHEMBL19737716 0.88 NPC1 (0.66) LIMK1MAPTNPC1MEN1KMT2A
SCHEMBL19737575 0.86 MAPT (0.62) LIMK1MAPTNPC1MEN1KMT2A
SCHEMBL19737757 0.85 MAPT (0.63) LIMK1MAPTNPC1MEN1KMT2A
SCHEMBL19737714 0.84 LIMK1 (0.58) LIMK1MAPTNPC1MEN1KMT2A
SCHEMBL19737571 0.84 LIMK1 (0.58) LIMK1MAPTNPC1MEN1KMT2A
SCHEMBL19737511 0.84 LIMK1 (0.60) LIMK1MAPTNPC1MEN1KMT2A
SCHEMBL19737519 0.81 LIMK1 (0.57) LIMK1MAPTNPC1MEN1KMT2A
SCHEMBL19737755 0.80 LIMK1 (0.56) LIMK1MAPTNPC1MEN1KMT2A
SCHEMBL21051640 0.79 MAPT (0.54) LIMK1MAPTNPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10689394-B2 Thieno[2,3-b]pyridine derivative, quinoline derivative, and use thereof THE UNIVERSITY OF TOKYO (JP) 2020-06-23 — — US claimed
US-20190177336-A1 THIENO[2,3-b]PYRIDINE DERIVATIVE AND QUINOLINE DERIVATIVE, AND USE THEREOF THE UNIVERSITY OF TOKYO (JP) 2019-06-13 — — US claimed
US-10689394-B2 Thieno[2,3-b]pyridine derivative, quinoline derivative, and use thereof THE UNIVERSITY OF TOKYO (JP) 2020-06-23 — — US disclosed
US-10689394-B2 Thieno[2,3-b]pyridine derivative, quinoline derivative, and use thereof THE UNIVERSITY OF TOKYO (JP) 2020-06-23 — — US disclosed
US-20190177336-A1 THIENO[2,3-b]PYRIDINE DERIVATIVE AND QUINOLINE DERIVATIVE, AND USE THEREOF THE UNIVERSITY OF TOKYO (JP) 2019-06-13 — — US disclosed
US-20190177336-A1 THIENO[2,3-b]PYRIDINE DERIVATIVE AND QUINOLINE DERIVATIVE, AND USE THEREOF THE UNIVERSITY OF TOKYO (JP) 2019-06-13 — — US disclosed
WO-2017217439-A1 THIENO[2,3-b]PYRIDINE DERIVATIVE AND QUINOLINE DERIVATIVE, AND USE THEREOF 国立大学法人東京大学 2017-12-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10689394-B2 Thieno[2,3-b]pyridine derivative, quinoline derivative, and use thereof BRD4, DRD4, TH LIMK1 4598/4885MAPT 3704/4885NPC1 2970/4885
US-20190177336-A1 THIENO[2,3-b]PYRIDINE DERIVATIVE AND QUINOLINE DERIVATIVE, AND USE THEREOF DERL1, UBQLN1, ADRM1 LIMK1 3789/4885MAPT 882/4885NPC1 1712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.